About ADISO THERAPEUTICS INC
Adiso Therapeutics is a biopharmaceutical company focused on developing novel therapies for inflammatory diseases, with a pipeline of multi-modal agents targeting respiratory and dermal inflammation, as well as neurodegenerative diseases.
Development of first-in-class dual inflammasome inhibitor (NLRP1 NLRP3) small molecule (ADS032) for respiratory and dermal inflammationCreation of orally dosed, naturally occurring single-strain live biotherapeutic product (SS-LBP) (ADS024) for neurodegenerative and neuroinflammatory diseases
Is this your company?
Claim ADISO THERAPEUTICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim ADISO THERAPEUTICS INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.